Alzheimer's & Dementia
Plasma eMTBR-tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes
Study in peopleBiomarkers
Papers by Val J. Lowe
54 results
- JAMA Neurology
A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease
Cross-sectional study of 681 peopleTau PET
- AAIC 2025 Abstract
In vivo detectability of tau‐PET tracers in Alzheimer's disease
Study in peopleBiomarkers - AAIC 2025 Abstract
Harmonization of Flortaucipir, MK6240, PI2620 and RO948 with the Uniτ scale
Study in peopleBiomarkers - AAIC 2025 Abstract
Defining tau PET positivity grey zones for MK6240 and Flortaucipir quantification
Study in peopleBiomarkers - AAIC 2025 Abstract
Tau‐PET overlap index correlates with neuropathology findings in early‐Braak stage
Study in peopleBiomarkers - AAIC 2025 Abstract
Impact of Medication Use on [18F]MK6240 and [18F]Flortaucipir Uptake in Alzheimer's disease
Study in peoplePopulations - AAIC 2025 Abstract
Creating a multi‐centre Amyloid PET dataset for DLB patients: Design and Methodology
Study in peopleAI & data - AAIC 2025 Abstract
Longitudinal progression and harmonization of tau‐PET tracers
Study in peopleBiomarkers - AAIC 2025 Abstract
Tau‐PET and plasma GFAP association in cognitively unimpaired Aβ‐PET negative individuals
Study in peopleBiomarkers - AAIC 2025 Abstract
User‐friendly tools for tau PET harmonization in clinical trials: The Uniτ Ecosystem
Study in peopleAI & data - AAIC 2025 Abstract
Diagnostic performance of MK and Flortaucipir tau PET for the biological staging of Alzheimer disease
Study in peopleBiomarkers - AAIC 2025 Abstract
Head‐to‐head trajectories of MK6240, Flortaucipir, and plasma p ‐tau217 as a function of Aβ
Study in peopleBiomarkers